Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DIVISLAB | BSE
-52.00
-1.39%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
08/12/2023
3,681.35
3,703.60
3,744.90
3,663.00
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates and nutraceutical ingredients in India the United States Asia Europe and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids as well as markets vitamins to nutritional pharma food/beverage and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad India.
View LessLow 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Price Below SMA10D
Weak P/E, and PEG ratio indicator
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
17.9%1 month
15.6%3 months
19.6%6 months
21.7%75.76
0
7.81
0.00
0.00
42.87
13.17
0
18.79B
977.37B
11.72B
0.79
20.12
-28.50
2.90
10.73
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
172.25
Range1M
363.70
Range3M
557.40
Rel. volume
0.75
Price X volume
23.26M